Search - tctmd.com

Displaying 341 - 360 of 685

Sort: Relevancy | Date

Presentation TCT 2017

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Presenter: Giulio G. Stefanini, Stephan Windecker, Renu Virmani

October 30, 2017

Presentation TCT 2017

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Presenter: Stephen G. Ellis, David E. Kandzari, Sigmund Silber

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, David J. Maron

October 30, 2017

Presentation TCT 2017

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

Presenter: Stephen G. Ellis, David E. Kandzari, Tullio Palmerini

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Carlo Di Mario

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Philippe Genereux

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 4: NILE Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Ivo Petrov

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 3: BIOSS Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Ricardo A. Costa

October 30, 2017

Presentation TCT 2017

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

Bifurcation Stents 2: AXXESS Plus Description, Data, and Case Examples

Presenter: Alaide Chieffo, Jeffrey W. Moses, Fausto Feres

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Gregory J. Dehmer

October 30, 2017

Presentation TCT 2017

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

Presenter: Alaide Chieffo, Jeffrey W. Moses, Martin B. Leon

October 30, 2017

Presentation TCT 2017

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Holger Thiele

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Navin K. Kapur

October 30, 2017

Presentation TCT 2017

Origin of Thromboemboli in Atrial Fibrillation: Valvular vs Non-Valvular AF, Large vs Small Left Atria, and Other Considerations

Presenter: Christopher B. Granger, Horst Sievert, Renu Virmani

October 30, 2017

Presentation TCT 2017

The Global Vision of Cardiovascular Regenerative Medicine: The TACTICS Alliance

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles

October 30, 2017

Presentation TCT 2017

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Presenter: Julinda Mehilli, Giulio G. Stefanini, Sunil V. Rao

October 30, 2017

Presentation TCT 2017

Case #8: Transseptal Mitral ViMAC With SAPIEN 3 (With Discussion)

Presenter: Mayra Guerrero, Nicolas M. Van Mieghem

October 30, 2017

Presentation TCT 2017

The American Vision of Regenerative Cardiovascular Medicine

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles

October 30, 2017

Advertisement

Are There Meaningful Differences Between Current Durable Polymer-Based vs Bioabsorbable Polymer-Based vs Polymer-Free Metallic DES? Pathologic Insights

Promus Element Everolimus-Eluting Stents: Device Iterations and Randomized/Registry Outcomes Data in Perspective

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

XIENCE Everolimus-Eluting Stents: Device Iterations, Randomized/Registry Outcomes Data in Perspective and the Move to Shorter DAPT

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Bifurcation Stents 1: TRYTON Description, Data, and Case Examples

Bifurcation Stents 4: NILE Description, Data, and Case Examples

Bifurcation Stents 3: BIOSS Description, Data, and Case Examples

Case Resolution: STEMI, Cardiogenic Shock, and Cardiac Arrest How We Treated

Bifurcation Stents 2: AXXESS Plus Description, Data, and Case Examples

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the US Guidelines and AUC Say?

Is There a Need for Dedicated Bifurcation Stents (Bare Metal or Drug-Eluting)?

STEMI With Cardiogenic Shock and Cardiac Arrest: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With STEMI, Cardiogenic Shock, and Cardiac Arrest How Should We Treat?

Origin of Thromboemboli in Atrial Fibrillation: Valvular vs Non-Valvular AF, Large vs Small Left Atria, and Other Considerations

The Global Vision of Cardiovascular Regenerative Medicine: The TACTICS Alliance

Small Vessel Stenting Snapshot 2: The Svelte Sirolimus-Eluting Stent

Case #8: Transseptal Mitral ViMAC With SAPIEN 3 (With Discussion)

The American Vision of Regenerative Cardiovascular Medicine

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content